vs
Side-by-side financial comparison of INVESTORS TITLE CO (ITIC) and STEM, INC. (STEM). Click either name above to swap in a different company.
INVESTORS TITLE CO is the larger business by last-quarter revenue ($69.5M vs $47.1M, roughly 1.5× STEM, INC.). On growth, INVESTORS TITLE CO posted the faster year-over-year revenue change (-1.6% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 14.0%).
The Real Estate Title Insurance Company of Philadelphia was the world's first title insurance company.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
ITIC vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $69.5M | $47.1M |
| Net Profit | — | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | 13.8% | -17.7% |
| Net Margin | — | -33.9% |
| Revenue YoY | -1.6% | -15.6% |
| Net Profit YoY | — | 68.8% |
| EPS (diluted) | $3.97 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $69.5M | $47.1M | ||
| Q3 25 | $73.0M | $38.2M | ||
| Q2 25 | $73.6M | $38.4M | ||
| Q1 25 | $56.6M | $32.5M | ||
| Q4 24 | $70.6M | $55.8M | ||
| Q3 24 | $68.8M | $29.3M | ||
| Q2 24 | $65.4M | $34.0M | ||
| Q1 24 | $53.5M | $25.5M |
| Q4 25 | — | $-16.0M | ||
| Q3 25 | $12.2M | $-23.8M | ||
| Q2 25 | $12.3M | $202.5M | ||
| Q1 25 | $3.2M | $-25.0M | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | $9.3M | $-148.3M | ||
| Q2 24 | $8.9M | $-582.3M | ||
| Q1 24 | $4.5M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | 13.8% | -17.7% | ||
| Q3 25 | 20.7% | -33.6% | ||
| Q2 25 | 21.5% | -34.8% | ||
| Q1 25 | 7.2% | -65.0% | ||
| Q4 24 | 15.3% | -84.4% | ||
| Q3 24 | 16.8% | -493.2% | ||
| Q2 24 | 17.2% | -1705.5% | ||
| Q1 24 | 10.8% | -267.0% |
| Q4 25 | — | -33.9% | ||
| Q3 25 | 16.7% | -62.2% | ||
| Q2 25 | 16.7% | 527.8% | ||
| Q1 25 | 5.6% | -76.9% | ||
| Q4 24 | — | -91.6% | ||
| Q3 24 | 13.5% | -506.3% | ||
| Q2 24 | 13.6% | -1712.6% | ||
| Q1 24 | 8.5% | -283.9% |
| Q4 25 | $3.97 | $-4.40 | ||
| Q3 25 | $6.45 | $-2.84 | ||
| Q2 25 | $6.48 | $-1.79 | ||
| Q1 25 | $1.67 | $-0.15 | ||
| Q4 24 | $4.41 | $-15.29 | ||
| Q3 24 | $4.92 | $-18.24 | ||
| Q2 24 | $4.70 | $-71.81 | ||
| Q1 24 | $2.40 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.6M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $268.3M | $-249.4M |
| Total Assets | $363.1M | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.6M | $48.9M | ||
| Q3 25 | $110.8M | $43.1M | ||
| Q2 25 | $90.1M | $40.8M | ||
| Q1 25 | $81.7M | $58.6M | ||
| Q4 24 | $83.8M | $56.3M | ||
| Q3 24 | $112.9M | $75.4M | ||
| Q2 24 | $111.2M | $89.6M | ||
| Q1 24 | $135.0M | $112.8M |
| Q4 25 | $268.3M | $-249.4M | ||
| Q3 25 | $278.0M | $-235.7M | ||
| Q2 25 | $266.2M | $-214.1M | ||
| Q1 25 | $254.4M | $-417.5M | ||
| Q4 24 | $251.8M | $-398.4M | ||
| Q3 24 | $271.3M | $-344.1M | ||
| Q2 24 | $261.8M | $-203.2M | ||
| Q1 24 | $254.0M | $371.6M |
| Q4 25 | $363.1M | $308.9M | ||
| Q3 25 | $363.3M | $362.6M | ||
| Q2 25 | $345.8M | $379.2M | ||
| Q1 25 | $333.8M | $405.1M | ||
| Q4 24 | $333.6M | $437.4M | ||
| Q3 24 | $352.0M | $537.8M | ||
| Q2 24 | $340.3M | $691.5M | ||
| Q1 24 | $329.5M | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $30.9M | $8.2M |
| Free Cash FlowOCF − Capex | $25.4M | — |
| FCF MarginFCF / Revenue | 36.5% | — |
| Capex IntensityCapex / Revenue | 8.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $47.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $30.9M | $8.2M | ||
| Q3 25 | $17.2M | $11.4M | ||
| Q2 25 | $8.9M | $-21.3M | ||
| Q1 25 | $-75.0K | $8.5M | ||
| Q4 24 | $29.8M | $-14.7M | ||
| Q3 24 | $7.8M | $-9.4M | ||
| Q2 24 | $8.4M | $-11.9M | ||
| Q1 24 | $1.4M | $-621.0K |
| Q4 25 | $25.4M | — | ||
| Q3 25 | $15.8M | — | ||
| Q2 25 | $7.3M | — | ||
| Q1 25 | $-1.4M | — | ||
| Q4 24 | $22.4M | — | ||
| Q3 24 | $6.1M | — | ||
| Q2 24 | $6.3M | — | ||
| Q1 24 | $-793.0K | — |
| Q4 25 | 36.5% | — | ||
| Q3 25 | 21.7% | — | ||
| Q2 25 | 9.9% | — | ||
| Q1 25 | -2.5% | — | ||
| Q4 24 | 31.7% | — | ||
| Q3 24 | 8.8% | — | ||
| Q2 24 | 9.7% | — | ||
| Q1 24 | -1.5% | — |
| Q4 25 | 8.0% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 10.5% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | 4.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.40× | — | ||
| Q2 25 | 0.72× | -0.11× | ||
| Q1 25 | -0.02× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.95× | — | ||
| Q1 24 | 0.32× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
